Castle Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Castle Biosciences, Inc.‘s stocks are currently a part of 91 hedge funds’ portfolios, which represents 45.92% of the total amount of its stocks outstanding. This makes up a total of 11.96M shares of Castle Biosciences, Inc.. Compared to the previous quarter, the number fell by -46.04% or -10.20M shares fewer. As for the holding position changes, 43.96% (40) of current hedge fund investors increased the number of shares held, 25.27% (23) of current holders sold a part of the shares held, and 9.89% (9) closed the holdings completely. 10 hedge funds are new holders of Castle Biosciences, Inc. stock in Q1 2023, it is 10.99% of total holders.
Hedge funds holding Castle Biosciences (Q3 2019 – Q1 2023)
| Q3 2019 | 57 |
|---|---|
| Q4 2019 | 66 |
| Q1 2020 | 88 |
| Q2 2020 | 125 |
| Q3 2020 | 144 |
| Q4 2020 | 162 |
| Q1 2021 | 171 |
| Q2 2021 | 177 |
| Q3 2021 | 184 |
| Q4 2021 | 156 |
| Q1 2022 | 156 |
| Q2 2022 | 143 |
| Q3 2022 | 154 |
| Q4 2022 | 153 |
| Q1 2023 | 91 |
Hedge funds changes in Castle Biosciences positions (Q3 2019 – Q1 2023)
| Q3 2019 | 57 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2019 | 22 | 28 | 12 | 8 | -4 |
| Q1 2020 | 31 | 37 | 14 | 9 | -3 |
| Q2 2020 | 45 | 52 | 16 | 7 | 5 |
| Q3 2020 | 30 | 63 | 36 | 12 | 3 |
| Q4 2020 | 38 | 64 | 45 | 19 | -4 |
| Q1 2021 | 32 | 73 | 53 | 23 | -10 |
| Q2 2021 | 37 | 75 | 44 | 30 | -9 |
| Q3 2021 | 20 | 80 | 52 | 13 | 19 |
| Q4 2021 | 20 | 64 | 48 | 46 | -22 |
| Q1 2022 | 22 | 71 | 41 | 20 | 2 |
| Q2 2022 | 24 | 72 | 28 | 34 | -15 |
| Q3 2022 | 23 | 58 | 46 | 14 | 13 |
| Q4 2022 | 25 | 51 | 54 | 25 | -2 |
| Q1 2023 | 10 | 40 | 23 | 9 | 9 |
Hedge funds changes in Castle Biosciences stock options (Q3 2019 – Q1 2023)
| Q3 2019 | 0 | 0 |
|---|---|---|
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 264,000 |
| Q3 2020 | 0 | 689,000 |
| Q4 2020 | 8,168,000 | 3,029,000 |
| Q1 2021 | 2,320,000 | 12,104,000 |
| Q2 2021 | 7,267,000 | 1,767,000 |
| Q3 2021 | 2,141,000 | 725,000 |
| Q4 2021 | 313,000 | 214,000 |
| Q1 2022 | 332,000 | 0 |
| Q2 2022 | 630,000 | 0 |
| Q3 2022 | 3,245,000 | 3,000 |
| Q4 2022 | 918,060 | 143,594 |
| Q1 2023 | 0 | 0 |